Guardant Health Inc (GH) stock has fallen -74.03% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives GH stock a score of 28 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 1. GH's rank also includes a long-term technical score of 2. The fundamental score for GH is 81. In addition to the average rating from Wall Street analysts, GH stock has a mean target price of $129.50. This means analysts expect the stock to climb 309.42% over the next 12 months. GH has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on GH!